In this study, IHC staining was performed using CD34 antibodies on tumor tissue sections from 238 LUAD patients who underwent radical surgery to determine intratumoral MVD and to analyze the relationship between CD34-MVD and patient clinicopathological characteristics and survival. The gene discussed is CD34; the disease is neoplasm.